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Abstract. One of the most common oral ulcerations is recurrent aphthous 
stomatitis (RAS), affecting approximately 20% of the general population 
worldwide. The etiology of RAS is still unclear but it is considered to be 
multifactorial, including imbalanced nutrition intake and allergic conditions such 
as atopy. The purpose of this study was to investigate the differences and 
correlation between the serum level of IL-6, reactive oxygen species (ROS), and 
cortisol in RAS patients. Our study was cross-sectional and used a consecutive 
sampling method. There were significant differences of IL-6 and ROS levels in 
all groups (p = 0.000, p = 0.049 respectively) and a significant correlation 
between cortisol and ROS in the RAS group without atopy (r = -0.985, p = 
0.015). Serum IL-6 and ROS measurement may be used for detecting RAS 
caused by malnutrition or atopy but not cortisol for patients without 
psychological stress detected. This is consistent with the results of a very strong 
correlation with a negative value between cortisol and ROS in RAS without 
atopy. 
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1 Introduction 
Recurrent aphthous stomatitis (RAS) is a common oral mucosal disease, 
manifesting itself as multiple recurrent round or ovoid ulcers with necrotic 
centers, yellowish-grey pseudomembranes and well-defined erythematous 
margins. The prevalence of RAS worldwide varies from 5% to 50% depending 
on the ethnic and socioeconomic groups studied [1]. RAS is characterized by 
recurrent and painful ulceration on the non-keratinized oral mucosa, such as the 
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labial, buccal, and ventral tongue mucosa [2]. The prevalence of RAS was 
higher in women (57.2%) than in men (48.3%) among professional school 
students compared to 12 years later when the same subjects had become 
professional workers [3]. Several factors can induce RAS, including imbalanced 
nutrition intake and allergic conditions such as atopy [3,4]. Macro and 
micronutrients are needed for the body. In RAS patients a lack of micronutrients 
is often found, such as ferritin, folate, or vitamin B12, which is known as a 
hematinic [5]. It is known that RAS patients can also be atopic or have clinical 
or latent atopy [6]. Our previous investigation found that there was a correlation 
between RAS and atopy based on higher serum IgE levels in RAS patients 
compared to the control group [7].  
RAS is an inflammatory disease, where cytokine plays an important role in the 
immune process. The level of pro-inflammatory cytokines, including IL-6, is 
raised in RAS [8,9]. Physiological concentrations of IL-6 are relatively low (1-5 
pg/mL) in the human serum [10]. The serum level of IL-6 in RAS patients is 
elevated in response to early indicators of inflammation, which is integral to the 
immunological host defense [11]. External factors involved in RAS such as 
food (nutrition) or some allergen in the case of an allergic condition related to 
RAS can induce oxidative stress, which is involved in several pathological 
conditions [12]. Oxidative stress occurs when there is an imbalance between the 
production of reactive oxygen species (ROS) and antioxidants. A previous study 
has shown that the serum total antioxidant status (TAS) level in RAS patients 
was significantly decreased, whereas the serum level of nitric oxide (NO) was 
significantly higher, both compared to healthy individuals [13]. Another study 
has confirmed a significant elevation of the malondialdehyde level and a 
significant decrease of glutathione peroxidase activity and of the levels of 
vitamin E and selenium in RAS [14].  
Another condition related to RAS is psychological stress, on which several 
studies have been carried out. Gallo, et al. used a questionnaire to measure the 
frequency and intensity of stress symptoms in RAS patients and found higher 
stress levels in the RAS group than the control group during active episodes 
[15]. A study on anxienty and depression in RAS patients revealed that their 
score on the State-Trait Anxiety Inventory-Trait Scale (STAI-T) was higher 
when compared to the control group [16]. Farmaki, et al. revealed that salivary 
and serum cortisol concentrations and anxiety levels in RAS patients were 
significantly higher than in the control group [17]. Stress always leads to 
decreased immunity, characterized by an increase in glucocorticoid secretion. 
Stress influences the immune system through two routes: the hypothalamus–
pituitary–adrenal (HPA) axis and the autonomic nervous system. Interleukin-6 
(IL-6) as an inflammatory cytokine is known to play a role in modulating the 
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HPA axis response at all three levels: hypothalamus, pituitary gland, and 
adrenal glands [18].  
Although research on IL-6, ROS, and cortisol levels in RAS has been done by 
previous researchers separately, no studies have been done to link IL-6, ROS, 
and cortisol in RAS patients. The present study aimed to investigate the 
differences and correlation between the serum levels of IL-6, reactive oxygen 
species (ROS), and cortisol in RAS patients with and without atopy.  
2 Materials and Methods 
A total of 27 subjects were evaluated in this study at the dr. Hasan Sadikin 
General Hospital, Bandung in August-October 2018. This study was cross-
sectional and used the consecutive sampling method. The diagnosis of RAS is 
typically established from history taking and clinical presentation [1]. The 
inclusion criteria were age between 20-40 years old, male and female, having 
recurrence of RAS more than twice every year, lack of balanced nutrition based 
on history taking (lack of vegetable consumption or other imbalanced food 
intake), low level of routine hematological screening, and a history of atopic 
disease (atopic dermatitis/allergic rhinitis/bronchial asthma). Exclusion criteria 
were subjects having severe blood abnormalities based on history taking, oral 
lesions found such as herpetic stomatitis or traumatic ulcers. This study was 
approved by the Health Research Ethics Committee of Universitas Padjadjaran 
with Registry Number 977/UN6.KEP/EC/2018.  
After obtaining written informed consent, a 5-ml blood sample was collected 
from each participant in the morning by a laboratory assistant from the clinical 
pathology laboratory of Dr. Hasan Sadikin Hospital. IL-6 serum levels were 
measured using human enzyme-linked immunosorbent assay (ELISA) kit 
(Elabscience®). ROS serum levels were measured using a human ROS ELISA 
kit with category number MBS2603394. Cortisol serum levels were assayed by 
electrochemiluminescence immunoassay (ECLIA) Cobas e 601 (Cortisol No. 
11875116 122, Roche). 
Statistical analysis was performed using SPSS software, version 18.0 (Chicago, 
Illinois, USA). The Kolmogorov-Smirnov and Shapiro-Wilk tests were used to 
test the normality of the data, multivariate analysis (one-way Anova) was 
carried out to assess the difference between IL-6, ROS, and cortisol levels in the 
RAS patient group, which was divided into two (with and without atopy), and 
control. A p-value less than 0.005 was considered statistically significant (See 
Figure 1).  
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Figure 1 Research flow chart. 
3 Results  
The RAS patient group consisted of two males and ten females, ranging in age 
from 21 to 39 years, while the control group consisted of 15 gender- and age-
matched subjects (three males and twelve females) (Table 1). 
Table 1 Characteristics of subjects. 
No. Category 
 RAS with 
atopy  
(n = 8) 
 RAS without 
atopy  
(n = 4) 
Control  
(n = 15) 
1 Age (year) 
20-30 5 3 10 
>30 3 1 5 
2 Sex 
Female 6 4 12 
Male 2 0 3 
3 Atopy 
Allergic Rhinitis (AR) 3 0 0 
Atopic Dermatitis (AD) 3 0 0 
Bronchial Asthma (BA) 2 0 0 
The box plot for the three groups shows a normal distribution (Figures 2-4). The 
p-value data of IL-6 (pg/ml) and cortisol (nmol/L) were greater than alpha = 5% 
or 0.229 and 0.849 > 0.05. The IL-6 data (pg/ml) and cortisol (nmol/L) were 
normally distributed.  
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Figure 3 Box plot of RAS without atopy, n = 4 for IL-6 (a), ROS (b) and 
cortisol levels (c). 
  
Figure 4 Figure Box plot of control, n = 15 for IL-6 (a), ROS (b) and cortisol 
levels (c). 
Table 2 Normality Test of IL-6, ROS, Cortisol levels. 
Normality Test 
 RAS with atopy 
(n = 8) 
RAS without atopy 
(n = 4) 
Control  
(n = 15) 
Kolmogorov-Smirnova  Statistic df Sig. Statistic df Sig. Statistic df Sig. 
IL-6 (pg/ml)  0.212 8 0.200* 0.338 4 - 0.249 15 0.13 
ROS (IU/ml) 0.307 8 0.25 0.353 4 - 0.229 15 0.33 
Cortisol (nmol/L) 0.169 8 0.200* 0.363 4 - 0.203 15 0.97 
Shapiro-Wilk          
IL-6 (pg/ml)  0.889 8 0.229 0.842 4 0.201 0.839 15 0.12 
ROS (IU/ml) 0.77 8 0.13 0.778 4 0.68 0.848 15 0.16 
Cortisol (nmol/L) 0.964 8 0.849 0.832 4 0.174 0.931 15 0.286 
* IL-6 and cortisol data show true significance       a. Lilliefors significance correction 
Based on the results of the normality test (Table 2), the cortisol (nmol/L) and 
ROS (IU/ml) of the RAS group without atopy were normally distributed. The 
next test was performed using the Pearson product-moment with r = -0.985 
(Table 3). The correlation test showed that there was a very strong relationship 
between cortisol (nmol/L) and ROS (IU/ml) at an interval of 0.800-1.000 with a 
negative relationship direction. The p-value obtained was 0.015. When 
compared with alpha 5%, the value was smaller than alpha, or 0.015 < 0.05, 
meaning that there was a significant relationship between cortisol (nmol/L) and 
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Table 3 Correlation analysis between IL-6, ROS, and Cortisol serum levels. 
Test of Correlation 




r Strength p-value r Strength p-value 
Spearman’s rank 






- - - 
0.025 very weak 0.93 
IL-6 and Cortisol - - - - - - -0.036 very weak 0.899 






- - - 
0.429 moderate 0.111 
Pearson product-
moment 
IL-6 and ROS - - - 0.004 very weak 0.996 - - - 
IL-6 and Cortisol -0.262 weak 0.531 0.071 very weak 0.929 - - - 
ROS and Cortisol 
- - - 
 
-0.985 
very strong 0.015 
- - - 
Multivariate analysis for the three groups showed that there was a significant 
difference between IL-6 (pg/ml) in all groups and a significant difference 
between ROS (IU/ml) in all groups (Table 4).  
Table 4 Difference analysis between IL-6, ROS, and Cortisol levels. 
Group n 
IL-6 (pg/ml) ROS (nmol/L) Cortisol (nmol/L) 


















8 30,2 624,2 241 213,64 
0.000* 
1,25 10,04 3,52 3,08 
0,049* 




4 8,5 764,2 278,57 333,77 1,23 7,84 3,31 3,07 119,8 276,3 201,05 49,55 
Control 15 1,2 31,2 9,51 9,29 0,64 3,33 1,53 0,74 92,7 214,8 170,15 53,33 
*Multivariate analysis (One Way ANOVA) 
4 Discussion 
The number of female RAS patients was higher than the number of male 
patients in this study, as in previous studies [19,20]. In this study we also found 
that women suffer from RAS and have allergic rhinitis (AR) more often than 
men, which is consistent with data that AR is often found in women and in the 
age range of 10-29 years [21]. Allergic rhinitis (AR) is a common disorder of 
the nose. The symptoms include nasal obstruction, rhinorrhoea, sneezing and 
nasal itching [22]. In this study, all AR patients who had RAS displayed one or 
more symptoms. 
Four patients in Group 2 were female. One patient said that she always 
experienced RAS during the menstrual period. Thangadurai, et al. revealed that 
the onset of RAS is more common during the third week of the menstrual cycle, 
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corresponding the luteal phase [23]. Previous studies have shown that women 
with menstrual cycle associated aphthae were more likely to have complete or 
partial remission when receiving therapeutic ovarian hormones; women with 
menstrual cycle unassociated aphthae were more likely to have no change or 
exacerbation. These differences were statistically significant (p < 0.001) [24].  
Three patients in the RAS group without atopy realized having RAS when 
under stress due to school exams or other problems. A stressful situation may 
induce immunoregulatory activity, but the pathophysiologic effects on patients 
are not uniform. Several previous studies have found a higher level of 
psychological stress among RAS group patients compared to the control group 
(p < 0.05) [15]. A more recent study showed that stressful life events were 
significantly associated with the onset of RAS episodes but not with the 
duration of the episodes [25]. Stress in RAS patients can elevate serum cortisol 
levels [26].  
ROS levels were higher in one patient in the RAS group without atopy. Based 
on history taking this patient noticed that the RAS events always coincided with 
the menstrual period. Menstruation is the periodic, organized shedding of the 
uterine lining, in response to the interactions of hormones produced by the 
hypothalamus, pituitary gland, and ovaries [27]. Free radicals are also involved 
in the reproductive physiology. The ovulatory response is commonly identified 
with inflammation and reactive oxygen species could be important mediators of 
those inflammatory reactions [28,29].  
Serum IL-6 levels in RAS with atopy were higher than in the other two groups, 
similar to our previous study on a different population group. It showed that 
serum IL-6 levels were significantly higher in the atopy with RAS group [30]. 
Interleukin 6 is a multifunctional cytokine that participates in the inflammatory 
response [10]. Interleukin 6 gene polymorphisms are also likely to be 
synergistic for increased IL-6 activity in RAS patients, as identified in a 
previous study [31]. IL-6 is emerging as an important mediator and novel 
therapeutic target for chronic inflammatory diseases [32]. Serum levels of IL-6 
were found statistically significantly higher in AD patients than in control in 
[33].  
Significant differences in the levels of ROS serum between the three groups can 
be explained by the presence of more predisposing factors in Group 1 than in 
the other groups so that free radicals from malnutrition and atopy greatly 
influenced the increase in ROS levels. A combination of antioxidant-deficiency 
and malnutrition may render individuals more vulnerable to oxidative stress 
[34]. All RAS patients experienced mild anemia with a slight decrease in 
hematological levels due to a lack of nutritional factors [35], especially 
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micronutrients, because the patients claimed to consume vegetables rarely [36]. 
Nutritional disorders could also have affected allergic conditions in 8 patients 
(RAS with atopy) who had a history of atopy. As previous studies have shown, 
nutrition can modify allergies [37]. The presence of food sensitization and 
allergies is a predictive of severe atopic dermatitis [38].  
Eight patients were in the RAS group with atopy, consisting of three patients 
RAS with atopic dermatitis (AD), three patients RAS with allergic rhinitis, and 
two patients RAS with bronchial asthma. Oxidative stress has been known to be 
implicated in atopic dermatitis for more than 15 years, mainly in the following 
three aspects: the presence of oxidative stress, increased oxidative stress during 
AD exacerbation, and decreased antioxidant capability [39]. There is evidence 
to suggest that an excess of ROS plays an important role in the pathogenesis of 
airway inflammation in allergic rhinitis [40]. Oxidative stress plays a critical 
role in the pathogenesis of asthma. It is strongly suggested that an increased 
level of ROS acts as a critical contributor to the induction of allergic airway 
inflammation. Oxidative stress has traditionally been considered to be a toxic 
byproduct of aerobic metabolism and a factor involved in tissue damage [41]. 
The aphthous process is believed to be initiated by stimulation of the mucosal 
keratinocytes by a currently unknown antigen, leading to T-lymphocyte 
stimulation and the liberation of cytokines and various interleukins. As a 
previous study has shown, oxidative stress plays a vital role in the 
pathophysiological component of lesion in recurrent aphthous ulceration [42].   
5 Conclusion 
A significant negative correlation was observed between ROS and cortisol in 
the RAS group without atopy, and a significant difference between IL-6 and 
ROS levels was seen in all groups. Collectively, this study suggests that these 
biomarkers may play a role in the pathophysiology of RAS. 
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